Prevention of neutrophil migration ameliorates rat lung allograft rejection.
Chemokines activate and recruit specific leukocyte subpopulations. We sought to determine whether neutrophil migration, which can contribute to the development of ischemia-reperfusion injury, correlates with lung allograft rejection. Orthotopic left lung allotransplantation was performed from Brown Norway (donor) to Fisher 344 (recipient) rats. Because the role of activated neutrophils in the development of allograft rejection is believed to be biphasic, we used specific CXC receptor inhibition with antileukinate in 2 dosing regimens. Recipients were allocated into 4 groups; A (early administration) received 2 doses of antileukinate (10.0 mg/kg) intramuscularly 24 h before and immediately after transplantation; B (continuous administration) continuously received antileukinate intraperitoneally (10.0 mg/kg/day) for 7 days after surgery. Groups A or B were compared with individual controls that received PBS alone. The progression of rejection was assessed radiographically. Histologic evaluation of allograft rejection based on pathologic rejection grade, performed on day 7, demonstrated significantly lower histologic rejection in group B compared with the control group (2.1+/-1.0 vs. 3.3+/-0.5; P=0.018), whereas there was no significant difference in group A compared with the control group. There were no significant differences between the aeration scores of groups A or B compared with their control groups. Our data suggest that neutrophils may play a promoting role in the development of allograft rejection, and blockage of neutrophil migration may suppress acute lung allograft rejection.
Hirayama
Shin
S
Department of Surgery II, Fukuoka University School of Medicine, Fukuoka, Japan.
Shiraishi
Takeshi
T
Shirakusa
Takayuki
T
Higuchi
Takao
T
Miller
Edmund J
EJ
D000818:Animals; D002465:Cell Movement / Q000187:drug effects; D006084:Graft Rejection / Q000188:drug therapy* / Q000276:immunology*; D008168:Lung / Q000166:cytology / Q000187:drug effects / Q000473:pathology; D016040:Lung Transplantation / Q000000981:diagnostic imaging / Q000276:immunology* / Q000379:methods; D008297:Male; D020556:Neutrophil Infiltration / Q000187:drug effects*; D009504:Neutrophils / Q000166:cytology / Q000187:drug effects*; D009842:Oligopeptides / Q000494:pharmacology / Q000627:therapeutic use; D013902:Radiography, Thoracic; D051381:Rats; D011914:Rats, Inbred BN; D014184:Transplantation, Homologous
D009842:Oligopeptides; C118980:antileukinate